Abstract
Chrozophora tinctoria is an annual plant of the family Euphorbiaceae, traditionally used as a laxative, a cathartic and an emetic. A methanolic extract of Chrozophora tinctoria (MEC) whole plant and an n-butanol fraction of Chrozophora tinctoria (NBFC) were analyzed by gas chromatography–mass spectrometry (GC-MS) to detect the phytochemicals. MEC and NBFC were tested for in vitro anti acetylcholinesterase (AChE) potential. The effect of both samples on intestinal propulsive movement and spasmolytic activity in the gastrointestinal tract (GIT) was also studied. About twelve compounds in MEC and three compounds in NBFC were tentatively identified through GC-MS. Some of them are compounds with known therapeutic activity, such as toluene; imipramine; undecane; 14-methyl-pentadecanoic acid methyl ester; and hexadecanoic acid. Both NBFC and MEC samples were checked for acute toxicity and were found to be highly toxic in a dose-dependent manner, causing diarrhea and emesis at 1 g/kg concentration in pigeons, with the highest lethargy and mortality above 3 g/kg. Both the samples of Chrozophora tinctoria revealed significant (p ≤ 0.01) laxative activity against metronidazole (7 mg/kg) and loperamide hydrochloride (4 mg/kg)-induced constipation. NBFC (81.18 ± 2.5%) and MEC (68.28 ± 2.4%) significantly increased charcoal meal intestinal transit compared to distal water (41.15 ± 4.3%). NBFC exhibited a significant relaxant effect (EC50 = 3.40 ± 0.20 mg/mL) in spontaneous rabbit jejunum as compared to MEC (EC50 = 4.34 ± 0.68 mg/kg). Similarly, the impact of NBFC on KCl-induced contraction was more significant than that of MEC (EC50 values of 7.22 ± 0.06 mg/mL and 7.47 ± 0.57 mg/mL, respectively). The present study scientifically validates the folk use of Chrozophora tinctoria in the management of gastrointestinal diseases such as constipation. Further work is needed to isolate the phytochemicals that act as diarrheal agents in Chrozophora tinctoria.
Keywords: Chrozophora tinctoria, acetylcholinesterase inhibitor, laxative, acute toxicity, spasmolytic
1. Introduction
Constipation is a gastrointestinal disorder characterized by infrequent and difficult bowel movements, partial evacuation of stools and reduced stool number. Constipation can be defined as “unsatisfactory defecation” [1]. Constipation involves many factors such as low fluid intake, low dietary fiber intake, physical inactivity, medications, irregular bowel habits, history of sexual abuse and neurological and hormonal disorders. It is common in women and people of African origin and is more common in older people than in the young. The symptoms connected with constipation are mild and periodic. They may be chronic and difficult to treat. However, some of the long-term problems associated with constipation are hepatic encephalopathy and inguinal hernia. There are two pathophysiologic mechanisms that can explain constipation. In the first one, slow transit constipation, intestinal peristalsis fails to pass luminal material through the colon, allowing more time for bacterial degradation and the reabsorption of salts and water, thus reducing stool number and weight. The second mechanism is functional outlet obstruction. In this mechanism, stools cannot evacuate fully due to abnormal function of the pelvic floor, the anus or the rectum, and thus one feels a sense of incomplete defecation [2]. Laxatives are used to treat constipation to evacuate the bowel without irritation. Laxatives are classified based on their relative potency. The order of potency is from purgative > cathartic > laxative. Laxatives are further assembled according to their mode of action, as either emollients or lubricants, stool softeners, hydrating agents, stimulants and bulk-forming agents or hydrophilic agents. Bulk-forming or hydrophilic laxatives contain dietary fibers which cause the stool to be bulkier and retain more water as well as forming an emollient gel and making it easier for peristaltic action to move the stool forward. Laxatives add water and bulk to the stool, and similarly, the larger stools help the bowel to contract and pass out the stool. Some bulking laxatives are rice bran, ripe papaya and ripe banana [3]. Plant extracts with promising laxative potential have been reported, diminishing characteristics of constipation by improving intestinal motility, defecation frequency and stool weight. Organic leaf extracts of Ecklonia cava exerted a significant laxative effect against loperamide-induced constipation in rats, improving stool recovery and gastrointestinal tract motility [4]. Similarly, extracts from leaves of Malva sylvestris have also been reported to alleviate constipation in rats [5]. Through scientific investigations, a significant number of potent chemicals have been reported from plants practiced in folk medicine. The plant Gallicolumba ferruginea is a widespread shrub growing at high altitude, 1300–2700 m above sea level, and is used in the management of constipation, intestinal parasite infestation and worm expulsion. Traditional therapeutic plants that are used for the curing of constipation are Agave americana, Aloe vera, Cassia angustifolia, Cucumis sativus, Coffea arabica, Grewia ferruginea, Linum usitatissimum, Medicago sativa, Plantago ovata (Psyllium), Prunus mallus, Rhamnus frangula and Rhamnus purshiana [6]. Different drugs such as Senna, Gaviscon, Exlax and Correctol are used to overcome the problem of constipation [7,8]. The problem associated with constipation is the regulation of GIT motility, and for this purpose, several prokinetic drugs have been designed. The first amongst these, cisapride, was one of the prokinetic agents but was withdrawn due to its effect of increasing cardiac arrhythmias [9]. Such reports have compelled researchers to explore medicinal plants as prime therapeutic alternatives that have less harmful effects compared to the drugs available today.
Chrozophora tinctoria is an annual plant (Figure 1) of the family Euphorbiaceae, sub-family Acalyphoideae, tribe Chrozophoreae and sub-tribe Chrozophorinae. This plant exists in Africa, Europe and tropical parts of Asia including India and Pakistan. The plant produces turnsole, which was used as a coloring agent used in the 15th–17th centuries. It gives luminescence to dyes and pigments. Chrozophora tinctoria is used as an antimicrobial, as an antinociceptive, for the treatment of pyrexia and for wound healing in diabetics [10]. Plants of Chrozophora are used traditionally as cathartics and emetics, to treat mouth ulcers, warts and skin burns, menstrual problems, GIT worms, abdominal and joint pain, jaundice and migraine. The leaves and seeds of members of the Chrozophora are consumed as laxatives in Ethiopia and Senegal, while its fruit juice is taken as a potent remedy for cold in Nepal. The plant is rich in alkaloids, flavonoids, phenylpropanoid glycosides and coumarins. HPLC analysis of the plant confirmed the presence of glucose, fructose, sucrose, raffinose, arabinose and ribose [11]. Almost all the species of Chrozophora are rich in flavonoids [12,13,14]. Five flavonoid glycosides have been documented from the aerial portions of Chrozophora tinctoria using its methanolic extract. These are: apigenin 7-O-β-D-[(6-p-coumaroyl)]-glucopyranoside, quercetin 3-O-rutinoside, apigenin 7-O-β-D-glucopyranoside, apigenin 7-O-β-D-[6-(3,4dihydroxybenzoyl)]-glucopyranoside (Chrozophorine) and acacetin 7-O-rutinoside [15]. These flavonoids possess effective therapeutic potential, including antiviral activity [16,17]. Besides this, about 35 flavonoids have been reported from the genus Chrozophora, with profound antioxidant, antipyretic, antimicrobial and antiproliferative activities [10]. In the current study, gas chromatography–mass spectrometry was used to scrutinize the crude methanolic extract and n-butanol fractions of Chrozophora tinctoria for phytochemicals with laxative activity for the treatment of constipation.
2. Results
2.1. GC-MS
2.1.1. Composition of MEC
About 12 compounds were identified tentatively in crude methanolic extract of Chrozophora tinctoria (MEC) as shown in Table 1, Figure 2 and Supplementary Table S1. These compounds include mostly benzene-containing derivatives, long-chain fatty acids, hydrocarbons and the tricyclic antidepressant imipramine. The peaks presented in Figure 1 are in line with the database of phytochemicals present in the GC-MS library. Compounds with a similarity index of more than 600 were selected. Likewise, the GC-MS analysis of MEC manifested the existence of numerous biologically active components at different retention times (minutes).
Table 1.
Peak No. | Retention Time (min) | SI | RSI | Area % | Probability | Compound Name | Formula | Molecular Weight | Library |
---|---|---|---|---|---|---|---|---|---|
1 | 1.21 | 828 | 893 | 0.23 | 25.72 | Toluene | C7H8 | 92 | Replib |
2 | 1.75 | 943 | 943 | 19.37 | 41.03 | o-Xylene | C8H10 | 106 | Replib |
3 | 3.25 | 641 | 976 | 0.02 | 36.57 | Imipramine | C19H24N2 | 280 | nist_msms |
4 | 3.36 | 606 | 802 | 0.15 | 23.31 | Undecane | C11H24 | 156 | Replib |
5 | 6.16 | 787 | 851 | 0.04 | 48.08 | Butylated Hydroxytoluene | C15H24O | 220 | Replib |
6 | 6.42 | 834 | 899 | 0.18 | 58.97 | Pentadecanoic acid, 14-methyl-, methyl ester | C17H34O2 | 270 | MAINLIB |
7 | 9.72 | 629 | 652 | 0.27 | 52.21 | Nonanoic acid, 9-(o-propylphenyl)-, methyl ester | C19H30O2 | 290 | MAINLIB |
8 | 12.42 | 897 | 908 | 0.45 | 73.48 | Hexadecanoic acid, methyl ester | C17H34O2 | 270 | Replib |
9 | 16.57 | 799 | 812 | 0.55 | 8.15 | 10-Octadecenoic acid, methyl ester | C19H36O2 | 296 | MAINLIB |
10 | 17.31 | 630 | 724 | 0.04 | 25.25 | Heptadecanoic acid, 9-methyl-, methyl ester | C19H38O2 | 298 | MAINLIB |
11 | 18.91 | 635 | 667 | 0.01 | 30.39 | Spirost-8-en-11-one, 3-hydroxy-, (3á,5à,14á,20á,22á,25R)- | C27H40O4 | 428 | MAINLIB |
12 | 27.64 | 674 | 718 | 0.01 | 41.20 | 1-Monolinoleoylglycerol trimethylsilyl ether | C27H54O4Si2 | 498 | MAINLIB |
SI: similarity index; RSI: relative similarity index.
2.1.2. Composition of NBFC
Taking into account the similarity index of more than 600, an NBFC chromatogram (Figure 3) shows the presence of three bioactive compounds, i.e., pidolic acid; pentadecanoic acid, 14-methyl-, methyl ester; and 9-octadecenoic acid, methyl ester, (E), with similarity indexes of 666, 770 and 721 respectively (Table 2). The structures of these three compounds are presented in Supplementary Table S2.
Table 2.
Peak No. | Retention Time (min) | SI | RSI | Area % | Probability | Compound Name | Formula | Class | Molecular Weight | Library |
---|---|---|---|---|---|---|---|---|---|---|
1 | 5.44 | 666 | 885 | 0.01 | 12.91 | Pidolic Acid | C5H7NO3 | Amino acid derivative | 129 | MAINLIB |
2 | 12.19 | 770 | 867 | 0.01 | 67.68 | Pentadecanoic acid, 14-methyl-, methyl ester | C17H34O2 | Fatty acid | 270 | MAINLIB |
3 | 16.60 | 721 | 788 | 0.01 | 8.72 | 9-Octadecenoic acid, methyl ester, (E)- | C19H36O2 | Fatty acid | 296 | Replib |
2.2. Acetylcholinesterase Inhibitory Activity
Effect of MEC and NBFC
MEC and NBFC inhibited AchE at different concentrations as shown in Table 3. At a high concentration of 1000 µg/mL, MEC and NBFC inhibited the enzyme by 83.33 ± 3.51% and 73.33 ± 3.06% respectively. Similarly, the IC50 values (µg/mL) measured for MEC and NBFC were 40 and 110, respectively. Galantamine was used as standard with IC50 = 5.0 µg/mL.
Table 3.
Compound/Plant | Extract/Fraction | Concentration (µg/mL) | % AChE Inhibition | IC50 (µg/mL) |
---|---|---|---|---|
Galantamine | Standard | 1000 | 95.67 ± 2.52 | 5.0 |
500 | 87.33 ± 2.52 | |||
250 | 82.67 ± 3.06 | |||
125 | 77.00 ± 3.00 | |||
Chrozophora
tinctoria |
MEC | 1000 | 83.33 ± 3.51 | 40 |
500 | 73.00 ± 3.00 | |||
250 | 68.33 ± 4.51 | |||
125 | 61.00 ± 2.00 | |||
NBFC | 1000 | 73.33 ± 3.06 | 110 | |
500 | 65.00 ± 2.65 | |||
250 | 57.67 ± 2.08 | |||
125 | 50.33 ± 2.52 |
Values are expressed as mean ± SEM. Statistical significance was determined using IC50 values through Biostata software. IC50 = half-maximal inhibitory concentration; MEC= methanolic extract of C. tinctoria; AChE = Acetylcholinesterase; NBFC = n-butanol fraction of Chrozophora tinctoria.
2.3. Acute Toxicity
Acute Toxicity of MEC and NBFCT
The acute toxicities of MEC and NBFC are presented in Table 4. Doses of MEC and NBFS up to 0.5 g/kg did not produce toxic symptoms; however, diarrhea and emesis were observed at a concentration of 1 g/kg or more. MEC was emetic and diarrheal at concentrations of 4 and 5 g/kg with 50% mortality, while 50% and 75% mortality were noticed at concentrations of NBFC of 4 g/kg and 5 g/kg.
Table 4.
Sample | Dose (g)·(mL)/kg | Emesis | Diarrhea | Lethargy | Mortality (%) |
---|---|---|---|---|---|
Total Number of Vomits | Total Number of Wet Stools | ||||
Distal Water | 6 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | 0.00 ± 0.00 |
MEC | 0.3 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | 0.00 ± 0.00 |
0.5 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | 0.00 ± 0.00 | |
1 | 4.00 ± 1.00 | 9.33 ± 2.52 * | - | 0.00 ± 0.00 | |
2 | 5.00 ± 2.00 | 13.33 ± 2.52 *** | - | 0.00 ± 0.00 | |
3 | 7.00 ± 2.00 ** | 14.00 ± 4.58 *** | Less | 0.00 ± 0.00 | |
4 | 7.67 ± 2.52 ** | 14.33 ± 4.51 *** | More | 50.00 ± 0.00 | |
5 | 9.00 ± 2.65 *** | 16.33 ± 2.52 *** | More | 50.00 ± 0.00 | |
NBFC | 0.3 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | 0.00 ± 0.00 |
0.5 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | 0.00 ± 0.00 | |
1 | 3.00 ± 1.00 | 10.33 ± 3.51 * | - | 0.00 ± 0.00 | |
2 | 4.67 ± 1.53 | 14.67 ± 3.06 *** | Less | 0.00 ± 0.00 | |
3 | 5.00 ± 1.73 | 15.00 ± 5.00 *** | More | 25.00 ± 0.00 | |
4 | 6.00 ± 2.00 * | 16.00 ± 3.61 *** | Most | 50.00 ± 0.00 | |
5 | 7.33 ± 3.51 ** | 19.33 ± 3.51 *** | Most | 75.00 ± 0.00 |
Values are expressed as mean ± SEM. Statistical significance was determined using GraphPad Prism 6.01 software (one-way ANOVA followed by Tukey’s multiple comparison test), by Dotmatics, San Diego, CA, USA. * p ≤ 0.05 was considered statistically significant. (** p ≤ 0.01, *** p ≤ 0.001). MEC = methanolic extract of C. tinctoria; AChE = Acetylcholinesterase; NBFC = n-butanol fraction of Chrozophora tinctoria.
2.4. Laxative Activity
2.4.1. Effect on Metronidazole-Induced Constipation
The laxative (prokinetic) effect of MEC and NBFC was checked against metronidazole-induced constipation. It was observed that metronidazole (Metro) significantly (p < 0.001) attenuated the prokinetic effect of MEC by increasing the latency time and reducing the total number of stools, the number of wet stools and the percentage of wet stools, when compared with MEC + DW and control (castor oil) groups as shown in Table 5.
Table 5.
Samples | Dose g/kg ML/kg (P/O) |
First Stool/Latency Time (Minutes) |
Total Number of Stools | Number of Wet Stools | Weight of Stools (Grams) |
Percent of Wet Stools (%) |
---|---|---|---|---|---|---|
MEC + DW | 1 | 28.67 ± 2.08 | 17.00 ± 2.00 | 9.00 ± 2.00 | 13.27 ± 1.72 | 52.50 ± 5.63 |
2 | 27.33 ± 2.52 | 18.33 ± 2.52 | 13.00 ± 2.00 | 14.23 ± 2.06 | 70.80 ± 1.82 | |
3 | 25.00 ± 2.00 | 20.33 ± 0.58 | 15.00 ± 3.00 | 17.37 ± 2.07 | 73.57 ± 12.91 | |
Metronidazole (7 mg/kg) was administered (P.0) 30 min before extract/distal water/castor oil | ||||||
DW (-ive Control) | 6 | 73.33 ± 2.52 | 9.33 ± 2.52 | 00 ± 00 | 8.27 ± 1.96 | 00 ± 00 |
Castor oil (+ive Control) | 6 | 20.33 ± 2.52 *** | 22.00 ± 2.00 *** | 18.33 ± 1.53 *** | 18.67 ± 2.36 *** | 83.43 ± 2.23 *** |
MEC + Metro | 1 | 31.33 ± 1.53 *** | 14.00 ± 1.00 * | 6.33 ± 1.53 *** | 10.60 ± 1.75 | 44.88 ± 7.64 *** |
2 | 35.33 ± 2.52 *** | 15.67 ± 1.53 ** | 8.67 ± 1.53 *** | 12.33 ± 1.22 * | 55.02 ± 4.54 *** | |
3 | 37.33 ± 2.52 *** | 15.33 ± 1.53 | 9.33 ± 1.53 *** | 12.27 ± 1.32 | 60.86 ± 3.36 *** |
Data are presented as mean ± SEM; one-way ANOVA was done followed by Dunnett’s test to determine statistical significance where p ≤ 0.05 was considered statistically significant (* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001). MEC, methanolic extract of Chrozophora tinctoria; Metro, metronidazole; DW, distilled water; PO, per orally/by orally. Two asterisk (**) means data is significant compared to control while three asterisk (***) means its data is more significant compared to control.
Similarly, the laxative effect (prokinetic effect) of NBFC was also decreased to some extent by metronidazole as shown in Table 6.
Table 6.
Samples | Dose g/kg mL/kg (P/O) |
First Stool/Latency Time (Minutes) |
Total Number of Stools | Number of Wet Stools | Weight of Stools (Grams) |
Percent of Wet Stool (%) |
---|---|---|---|---|---|---|
NBFC + DW | 1 | 28.33 ± 2.52 | 17.00 ± 3.00 | 10.33 ± 1.53 | 13.37 ± 1.96 | 61.03 ± 2.87 |
2 | 26.33 ± 3.51 | 19.00 ± 2.00 | 14.33 ± 1.53 | 16.13 ± 2.70 | 75.45 ± 1.54 | |
3 | 23.33 ± 2.52 | 20.00 ± 1.00 | 16.67 ± 1.15 | 17.17 ± 2.16 | 83.31 ± 2.96 | |
Metronidazole (7 mg/kg) was administered (P.0) 30 min before fractions/distilled water/castor oil | ||||||
DW (−ive Control) | 6 | 73.33 ± 2.52 | 9.33 ± 2.52 | 00 ± 00 | 8.27 ± 1.96 | 00 ± 00 |
Castor oil (+ive Control) | 6 | 20.33 ± 2.52 *** | 22.00 ± 2.00 *** | 18.33 ± 1.53 *** | 18.67 ± 2.36 *** | 83.43 ± 2.23 *** |
NBFC + METRO | 1 | 29.33 ± 1.53 *** | 15.33 ± 0.58 ** | 7.67 ± 0.58 *** | 12.37 ± 1.56 * | 50.00 ± 3.34 *** |
2 | 30.67 ± 2.08 *** | 17.00 ± 2.65 *** | 11.67 ± 1.53 *** | 15.53 ± 1.60 *** | 64.72 ± 2.09 *** | |
3 | 21.67 ± 2.52 *** | 17.00 ± 2.00 *** | 13.67 ± 1.53 *** | 16.10 ± 2.05 *** | 80.43 ± 1.75 *** |
Data are presented as mean ± SEM; one-way ANOVA followed by Dunnett’s test was done to determine statistical significance where p ≤ 0.05 was considered statistically significant (* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001). NBFC, n-butanol fraction of Chrozophora tinctoria; Metro, metronidazole; DW, distilled water; PO, per orally/by orally.
2.4.2. Effect of Loperamide-Induced Constipation
MEC and NBFC were tested for laxative effect against loperamide hydrochloride (4 mg/kg)-induced constipation as presented in Table 7 and Table 8, respectively. Loperamide hydrochloride significantly (p < 0.001) reduced the prokinetic effect of MEC, either at 1 g/kg or 2 g/kg of MEC. Thus, the percentage of wet stools was significantly lowered either from 52.50 ± 5.63% to 37.51 ± 4.86 *** or from 70.80 ± 1.82% to 55.71 ± 5.15 *** correspondingly. Loperamide hydrochloride exhibited no significant effect against MEC at a concentration of 3 g/kg. A similar pattern of the prokinetic effect was observed for NBFC against loperamide-induced constipation, as shown in Table 8.
Table 7.
Samples | Dose g/kg mL/kg (P/O) |
First Stool/Latency Time (Minutes) |
Total Number of Stools | Number of Wet Stools | Weight of Stools (Grams) |
Percent of Wet Stool (%) |
---|---|---|---|---|---|---|
MEC + DW | 1 | 28.67 ± 2.08 | 17.00 ± 2.00 | 9.00 ± 2.00 | 13.27 ± 1.72 | 52.50 ± 5.63 |
2 | 27.33 ± 2.52 | 18.33 ± 2.52 | 13.00 ± 2.00 | 14.23 ± 2.06 | 70.80 ± 1.82 | |
3 | 25.00 ± 2.00 | 20.33 ± 0.58 | 15.00 ± 3.00 | 17.37 ± 2.07 | 73.57 ± 12.91 | |
Loperamide hydrochloride (4 mg/kg) was administered (P.0) 30 min before fractions/distilled water/castor oil | ||||||
DW (-ive Control) | 6 | 70.33 ± 2.52 | 8.33 ± 2.52 | 00 ± 00 | 7.50 ± 2.29 | 00 ± 00 |
Castor oil (+ive Control) | 6 | 17.33 ± 2.52 *** | 16.00 ± 2.00 ** | 14.33 ± 1.53 *** | 15.07 ± 1.27 *** | 89.74 ± 2.78 *** |
MEC + Lopr | 1 | 38.00 ± 3.00 *** | 11.33 ± 2.52 | 4.33 ± 1.53 *** | 8.90 ± 1.65 | 37.51 ± 4.86 *** |
2 | 25.00 ± 2.52 *** | 13.67 ± 1.53 * | 7.67 ± 1.53 *** | 11.00 ± 0.95 | 55.71 ± 5.15 *** | |
3 | 28.33 ± 2.52 *** | 13.67 ± 1.53 * | 10.00 ± 1.00 *** | 12.77 ± 1.37 ** | 73.15 ± 2.44 *** |
Data are represented as mean ± SEM. The data were analyzed by one-way ANOVA followed by Dunnett’s test using GraphPad Prism version 6.01; p ≤ 0.05 was considered significant (* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001). MEC, methanolic extract of Chrozophora tinctoria; Lopr, loperamide hydrochloride; DW, distilled water; PO, per orally/by orally.
Table 8.
Samples | Dose g/kg mL/kg (P/O) |
First Stool/Latency Time (Minutes) |
Total Number of Stools | Number of Wet Stools | Weight of Stools (Grams) |
Percent of Wet Stool (%) |
---|---|---|---|---|---|---|
NBFC + DW | 1 | 28.33 ± 2.52 | 17.00 ± 3.00 | 10.33 ± 1.53 | 13.37 ± 1.96 | 61.03 ± 2.87 |
2 | 26.33 ± 3.51 | 19.00 ± 2.00 | 14.33 ± 1.53 | 16.13 ± 2.70 | 75.45 ± 1.54 | |
3 | 23.33 ± 2.52 | 20.00 ± 1.00 | 16.33 ± 1.53 | 17.17 ± 2.16 | 81.55 ± 3.64 | |
Loperamide hydrochloride (4 mg/kg) was administered (P.0) 30 min before fractions/distilled water/castor oil | ||||||
Distilled Water (-ive Control) | 6 | 70.33 ± 2.52 | 8.33 ± 2.52 | 00 ± 00 | 7.50 ± 2.29 | 00 ± 00 |
Castor oil (+ive Control) | 6 | 17.33 ± 2.52 *** | 16.00 ± 2.00 ** | 14.33 ± 1.53 *** | 15.07 ± 1.27 *** | 89.74 ± 2.78 *** |
NBFC + Lopr | 1 | 32.33 ± 2.52 *** | 12.67 ± 2.08 | 5.67 ± 1.53 ** | 9.50 ± 1.65 | 44.34 ± 7.11 *** |
2 | 30.67 ± 2.08 *** | 16.33 ± 2.52 *** | 8.33 ± 1.53 *** | 11.33 ± 1.15 * | 50.88 ± 1.52 *** | |
3 | 24.33 ± 2.52 *** | 15.00 ± 2.00 ** | 13.33 ± 1.53 *** | 14.00 ± 2.17 *** | 89.06 ± 2.91 *** |
Data are represented as mean ± SEM. The data were analyzed by one-way ANOVA followed by Dunnett’s test using GraphPad Prism version 6.01; p ≤ 0.05 was considered significant (* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001). NBFC, n-butanol fraction of Chrozophora tinctoria; Lopr, loperamide hydrochloride; DW, distilled water; PO, per orally/by orally.
2.5. Gastrointestinal Motility (Charcoal Meal Method)
To understand the effects of the Chrozophora tinctoria fractions on intestinal motility, charcoal meal experiments were performed. The results obtained from the above concentrations were compared with distilled water and castor oil to determine the effect of concentration on intestinal motility. The methanolic extract of Chrozophora tinctoria manifested 53.1 ± 5.2% ***, 64.01 ± 5.2% *** and 68.28 ± 2.4% *** of intestine movement while n-butanol fraction displayed 45 ± 1.4% *, 66.46 ± 1.5% *** and 81.18 ± 2.5% *** intestinal transit at 25 mg/kg, 50 mg/kg and 100 mg/kg, respectively (Table 9).
Table 9.
Treatment | Dose (mg)·(mL)/Kg (PO) | Total Length of Intestine (cm) |
Total Distance Travelled by Charcoal Meal (cm) | % Intestinal Transit |
---|---|---|---|---|
Castor oil | 6 | 88.9 ± 5.1 | 77.7 ± 5.1 | 87.60 ± 5.8 *** |
Distilled Water | 6 | 90.9 ± 2.7 | 37.3 ± 2.8 | 41.15 ± 4.3 |
MEC | 25 | 76.4 ± 2.7 | 40.5 ± 3.0 | 53.1 ± 5.2 *** |
50 | 71.4 ± 2.4 | 45.6 ± 2.2 | 64.01 ± 5.2 *** | |
100 | 81.46 ± 1.8 | 55.6 ± 2.3 | 68.28 ± 2.4 *** | |
NBFC | 25 | 88.3 ± 2.01 | 45.2 ± 1.9 | 45 ± 1.4 * |
50 | 83.3 ± 2.9 | 55.4 ± 2 | 66.46 ± 1.5 *** | |
100 | 81.4 ± 2.4 | 66.1 ± 2 | 81.18 ± 2.5 *** |
Data are represented as mean ± SEM (* p ≤ 0.05; *** p ≤ 0.001). MEC, methanolic extract of Chrozophora tinctoria; NBFC, n-butanol fraction of Chrozophora tinctoria; DW, distilled water; PO, per orally/by orally; %, percentage.
2.6. Sposmolytic Activity
The methanolic extract of Chrozophora tinctoria was tested against spontaneous contraction of rabbit jejunum and KCl-induced (80 mM) contractions (Figure 4). At extract concentrations of 0.01, 0.03, 0.1 and 0.3 mg/mL concentration, no effect was seen. However, from 1 mg/mL to 10 mg/mL, the fraction was very effective in relaxing spontaneous rabbit jejunum contractions. Maximum results were noticed at 5 mg/kg and 10 mg/kg, with an EC50 of 4.34 ± 0.68 mg/kg. Similarly, the impact of the same fraction is also observed against a high concentration KCl-induced (80 mM) contraction. It was concluded that the fraction showed a significant relaxing effect at 3, 5 and 10 mg/mL with an EC50 of 7.47 ± 0.57 mg/mL.
As shown in Figure 5, the n-butanol fraction of Chrozophora tinctoria was checked against spontaneous rabbit jejunum responses. The impression of the fraction started from 0.03 mg/mL to 10 mg/mL, and the maximum relaxing effect was at 10 mg/mL with an EC50 value of 3.40 ± 0.20 mg/mL. The fraction with different concentrations was also evaluated against KCl-induced (80 mM) contraction. It was observed that the fraction was less potent at 0.03 mg/mL and was more influential at 10 mg/mL, with an EC50 value of 7.22 ± 0.06 mg/mL.
3. Discussion
Human beings have used medicinal plants in their traditional systems of medicine for centuries due to their medicinal properties. Natural products collected from microbes have been used as a source of antibiotics, but with the passage of time, there is increasing knowledge about herbal medicine. Herbal medicines have been used for health care, and screening of therapeutic plants for bioactive compounds has become important. Higher plants have been used as a source of active compounds as they are rich sources of secondary metabolites, and some chemotherapeutic agents come from plants. To gain knowledge and analyze medicinal plants to determine their bioactive compounds, GC-MS is normally used [18]. The GC-MS of the methanolic extract and n-butanol fraction of Chrozophora tinctoria showed the existence of diverse therapeutically active compounds, as shown in Table 1 and Table 2. Bioactive molecules such as toluene; imipramine; undecane; butylated hydroxytoluene; 14-methyl-pentadecanoic acid methyl ester; and hexadecanoic acid methyl ester, were significant and therapeutically active. Toluene has psychoactive effects when inhaled intentionally, and it is also used in paints, plastic production, lacquers, thinners and glues [19]. Imipramine is used to treat depression [20]. Undecane is used as an enzyme inhibitor, carcinogen and antimicrobial, and in various types of cockroaches and moths, it is used as a mild sex attractant [21]. Butylated hydroxytoluene is used as a food preservative and antioxidant [22]. Pentadecanoic acid, 14-methyl-, methyl ester is used as an antifungal, antimicrobial and antioxidant [23]. Hexadecanoic acid methyl ester is used as an antioxidant, nematocide, pesticide, hypocholesterolemic, hemolytic and 5-alpha reductase inhibitor [24].
Constipation is the most common gastrointestinal disorder in which an individual faces exceptional bowel movements with comparatively dry and hard stools occurring less than three times a week. About two million cases of this gastrointestinal complaint are reported in the world annually. Constipation causes include lack of liquids, lack of fiber in the diet, side effects of medications, irritable bowel syndrome, lack of exercise and other factors such as pregnancy and old age [25]. Constipation can be controlled by using nonpharmacologic agents such as sufficient liquid intake and use of dietary fibers and/or pharmacological agents used to control constipation including drugs such as laxatives, opioid antagonists, serotonin receptor agonists and colonic secretagogues [6]. In the current findings, it was found that the crude methanolic extract and importantly n-butanol fraction of Chrozophora tinctoria reduced constipation. Therefore, they can be used as therapeutic agents against constipation.
Acetylcholine (Ach) is a neurotransmitter in the brain and body organized for cholinergic transmission. Cholinesterase (acetylcholinesterase) belongs to the family of enzymes that hydrolyzes the neurotransmitter acetylcholine into choline and acetic acid. AchE inhibition is an auspicious plan of action against Alzheimer’s disease, myasthenia gravis, Parkinson’s disease, senile dementia and ataxia [26]. The first known acetylcholinesterase inhibitors such as physostigmine, tacrine and donepezil showed moderate development in the cognitive function of Alzheimer’s patients [27]. The bioactive compounds isolated from the plants have also shown inhibitory potential against acetylcholinesterase [28]. MEC and NBFC significantly inhibited AchE at various concentrations. The percent inhibition induced by MEC and NBFC at high concentration (1000 µg/mL) was 83.33 ± 3.51% and 73.33 ± 3.06%, with an inhibition concentration (IC50) equal to 40 µg/mL and 110 µg/mL, respectively. Due to the inhibition of AchE, the accumulation of acetylcholine occurs. The availability of acetylcholinesterase in higher concentrations results in a lengthened interaction with muscarinic and nicotinic receptors, keeping up the impulse. The cholinergic response boosts diarrhea through its intracellular signaling passageway [29,30]. The laxative effect of MEC and NBFC was observed in metronidazole (7 mg/kg)- and loperamide hydrochloride (4 mg/kg)-induced constipated pigeons. Both the fractions were found to be diarrheal. NBFC was found more laxative compared to MEC, and this higher prokinetic potential was attenuated by metronidazole more significantly than loperamide hydrochloride. The laxative effect of MEC and NBFC was further validated by the charcoal meal experiment. The effect of both the fractions of Chrozophora tinctoria was noted in intestinal motility. It was confirmed that both the fractions exhibited significant (p ≤ 0.05) propulsion of charcoal in the pigeon intestine.
The contraction of the intestine is due to intermittent depolarization of smooth muscles due to liberation of Ca+2, either from calcium influx or intracellular stores to the inside of the tissue with the help of voltage-gated calcium channels. High-level potassium chloride (KCl) is regarded as a depolarizer that can induce calcium influx into cells. The relaxation produced in KCl-induced contracted muscles generally shows that the tested material influences their activity through calcium channel blockade [31]. This research work was carried out to scrutinize the effect of MEC and NBFC on the smooth muscles of rabbit jejunum. The spasmolytic effect of MEC on the smooth muscles was observed at a concentration of 1 mg/mL. In the same way, the spasm produced by KCl (80 mM) in the jejunum was relaxed significantly at 5 mg/mL and 10 mg/mL with an EC50 of 7.47 ± 0.57 mg/mL. Similarly, the effect of NBFC was checked against spontaneous rabbit jejunum responses. The fraction started to have an effect from 0.03 mg/mL to 10 mg/mL, with the maximum relaxing effect at 10 mg/mL with an EC50 value of 3.40 ± 0.20 mg/mL. In the case of KCl-induced (80 mM) contraction, it was observed that NBFC was more influential at 10 mg/mL with an EC50 value of 7.22 ± 0.06 mg/mL. It was concluded that the relaxing effect of MEC and NBFC against spontaneous and KCl-induced (80 mM) contraction may be due to the inhibition of voltage-gated calcium channels. It proves that NBFC is more potent than MEC. Both the samples were also tested for acute toxicity on pigeons, and it was observed that doses of MEC and NBFC up to 0.5 g/kg were secure and nontoxic. However, MEC with concentrations of 4 and 5 g/kg was found to be emetic and diarrheal with 50% mortality, while 50% and 75% mortality was noticed at 4 g/kg and 5 g/kg concentration NBFC, respectively.
4. Materials and Methods
4.1. Chemicals and Solvents
The chemicals/drugs used in the present study were Flagyl (Sanofi Aventis (PVT) LTD, Karachi, Pakistan), gum acacia (Shreeji Pharma International, Vadodara, India), castor oil (Karachi Pharmaceuticals Laboratory, Karachi, Pakistan), Immodium (ASPIN Pharma PVT. LTD, Karachi, Pakistan), distilled water, normal saline (Shahzeb Pharmaceutical, Haripur, Pakistan), methanol, n-hexane, dichloromethane, ethyl acetate, n-butanol (Master chemical supplier, Karachi, Pakistan) and Tyrode solution (Khyber medical university, Peshawar, Pakistan).
4.2. Instruments
Instruments used were as follows: chopper machine; electric grinder; large and small flasks; separating funnel; vacuum rotary evaporator (Model RE-111, Labstac LLC, Pittsfield, MA, USA); analytical balance (Shimadzo analytical balance, Karachi, Pakistan); glass funnel; filter papers; disposable syringes of 5 cc, 3 cc, and 1 cc (Shifa disposable syringe), dissection kit (Haq chemicals, Peshawar, Pakistan); drip set (Shifa drip set, Karachi, Pakistan); feeding tube; water bath (Thermostatic controlled-STD/GMP); magnetic stirrer (H3760-S Digital magnetic stirrer); large and small cages; Petri dishes; power lab (Khyber medical university, Peshawar, Pakistan).
4.3. Plant Collection and Identification
Full and mature Chrozophora tinctoria plants were collected from District Mohmand (34.22° N to 71.48° E), Khyber Pakhtunkhwa, Pakistan, from mid-August to early September 2018. They were authenticated by Sher Wali (PhD), Assistant Prof. Department of Botany, Islamia College Peshawar. Following identification, the plant was given a voucher No. (CT-Bot-11082017), and a specimen was placed in the Herbarium, Department of Botany, Islamia College Peshawar. To clean the collected plant from dirt, it was washed with tap water and dried at room temperature in shade. After complete drying, the plant was cut into pieces and was ground down to powder using an electric grinder.
4.4. Extraction and Fractionation
Crude extract preparation: Ten kilograms of the powdered material of the plant was macerated in methanol for a week and agitated three times a day. The mixture was filtered using filter paper. The filtrate was concentrated through a vacuum rotary evaporator at 50 °C. Further drying was performed with a water bath at 50 °C to obtain a crude methanolic extract. The crude methanolic extract was divided into two portions; one was used as a crude methanolic extract, and the other part was fractionated with different solvents. The process of fractionation started by adding distilled water to the crude methanolic extract. After this, n-hexane was mixed into the mixture in a separating funnel, shaken gently so that the two layers mixed well and was then allowed to stand for 15 min to separate the two phases. The upper n-hexane phase was collected, and the lower aqueous phase in the separating funnel was re-extracted again with fresh n-hexane. All the fractions of n-hexane were concentrated using a rotary evaporator. A similar procedure was carried out for a series of solvents with increasing polarity, i.e., dichloromethane, ethyl acetate and n-butanol, to obtain their fractions. This method is called solvent–solvent fractionation. The crude methanolic fraction obtained in the first phase and n-butanol fraction in the last were used for further activities described in this work [32].
4.5. Gas Chromatography–Mass Spectrometry (GC-MS)
To understand which phytochemicals are present in the methanolic extract (MEC) and n-butanol fraction of Chrozophora tinctoria (NBFC), both samples were subjected to gas chromatography–mass spectrometry [33]. The plant samples were checked using a Thermo Scientific (DSQ-II) GC, furnished with a 30 m long TR-5MS capillary column and a 0.25 µm thick film with 0.25 mm of internal diameter. Helium was used as a carrier gas with a flow rate of 1 mL/min. The injection device was run in a split mode at 250 °C. The sample was injected, 1 µL at a time, with an initial oven temperature of 50 °C that was maintained for 2 min followed by gradually elevating the temperature to 150 °C at a rate of 8 °C/min. Ultimately, the temperature was increased to 300 °C at a speed of 15 °C/min and sustained for 5 min [34,35]. The mass spectrometry was performed in full scan mode to obtain information about mass fragments and mass/charge (m/z) ratio in the range of 50–600.
4.6. Pharmacological Activities
4.6.1. Laxative Activity
Healthy pigeons were arranged into eight groups (n = 8). The cages were provided with white, plastic bases for examination and stool collection. Groups 1, 2 and 3 were administered distilled water plus 1 g, 2 g and 3 g doses of both the fractions, respectively. Group 4 was given distilled water (6 mL/kg), and group 5 was given castor oil (6 mL/kg PO). Groups 6, 7 and 8 were given doses of 1 g, 2 g and 3 g of the testing fractions. Metronidazole (7 mg/kg) [36] and loperamide hydrochloride (4 mg/kg) [37] were administered to induce constipation in all the groups except groups 1, 2 and 3. Thirty minutes after, all the parameters, i.e., the first stool time/latency time (min), number of stools, number of wet stools and weight of stools (g), were recorded, and the percent effect was calculated as follows [38,39]:
(1) |
Healthy (with normal stools, non-lethargic, no nasal dropping, no weight loss, no shedding or feather ruffling and usual flying movement with regular feeding) and mature pigeons of either sex weighing 250–350 g were selected. They were provided a dark/light cycle for 12/12 h for 5–7 days and were allowed to drink fresh water and standard food (locally available food; millet + wheat grains).
On the day of the experiment, the pigeons were weighed and examined again for health condition. Pigeons observed as healthy were picked for the experiment, and those found unhealthy were removed from the experiment. The selected animals were caged separately to record data of individual pigeons of all groups [40]. All the pigeons were held gently, and fractions were administered orally.
4.6.2. In Vitro Experiments
Acetylcholinesterase Inhibitory Assay
Antiacetylcholinesterase activity was determined by applying the method of Ellman [41], with increasing concentrations of MEC and NBFC (125, 250, 500, 1000 µg/mL). The basic principle of this protocol is the hydrolysis of acetylthiocholine iodide into thiocholine using the respective enzyme, which reacts with 5, 5′-dithiobis-2-nitrobenzoic acid (DTNB) (Ellman’s reagent). The final products of the second reaction are 5-thio-2 nitrobenzoate and 2-nitrobenzoate-5-mercaptothiocholine. The absorption of the former product was measured with a spectrophotometer (412 nm). Galantamine, the positive control, was applied in the same concentrations as MEC and NBFC. All the tested samples were incubated at 37 °C for 20 min. The enzyme inhibition was calculated from the absorption rate with a change in time [41,42].
The percent enzyme inhibition was calculated as
Enzyme inhibition (%) = 100 − percent enzyme activity | (2) |
Percent enzyme activity (%) = 100 × V/Vmax | (3) |
where (Vmax) is an enzyme activity in the absence of an inhibitor.
4.6.3. In Vivo Experiments
Acute Toxicity
To check and establish the toxic effect of MEC and NBFC, we used a previously described protocol with some modifications [43]. The experimental animals (pigeons) were divided into two groups (n = 8). One group received plant extracts while the negative control group received distilled water only (6 mL/kg, PO). MEC and NBFC were administered orally with 0.3, 0.5, 1, 2, 3, 4 and 5 g/kg as a single dose to different groups using a feeding tube. All the pigeons were observed for toxic symptoms, i.e., diarrhea, emesis, lethargy and motility, for about 72 h [43].
Charcoal Meal Treatment
Pigeons were divided into five groups (n = 8). All the groups were constipated by administering loperamide hydrochloride at a dose of 4 mg/kg. Group 1 was given distilled water (2 mL); group 2 was served with castor oil; and groups 3, 4 and 5 were treated with fractions in concentrations of 25, 50, and 100 mg/kg, respectively. After 30 min, 2 mL of charcoal meal (a solution of 10% charcoal and 5% gum acacia) was given orally to each pigeon. All the pigeons were then provided with water and food and were sacrificed after 30 min. After that, the whole intestine, starting from the pylorus region to the ileocecal junction, was removed from the pigeons and placed on white paper parallel to a ruler. The distance traveled by the charcoal marker was measured and expressed as percent intestinal transit [44]. The percent effect was calculated as follows:
(4) |
Spasmolytic Activity
The spasmolytic effect of MEC and NBFC was evaluated according to earlier reported studies [45]. Mature and healthy male rabbits weighing 1.2–3.5 kg were subjected to spasmolytic activity. Briefly, following cervical dislocation [46], the abdomen of the rabbit was opened and the jejunum was cut into slices of 1.5–2.5 cm and placed in Petri plates having Tyrode solution with a continuous supply of carbogen gas (95% O2 and 5% CO2). The mesentery was removed from the isolated jejunum tissue and was fixed in the organ bath containing Tyrode solution at a retained temperature of 37 ± 1 °C and stabilized for about 20–30 min. The stable tissue with spontaneous response was taken as a baseline control, which is a positive control. The relaxing effect of the tested plant extract was compared. The effect of the fractions on spontaneous activity of the jejunum preparation was observed using different concentrations, i.e., 0.01, 0.03, 0.1, 0.3, 3.0, 5.0 and 10 mg/mL, at an interval of 1 to 2 min in a cumulative manner. The effect of the fractions was also tested against KCl-induced contraction [45].
4.7. Ethical Approval
The study was approved by the ethical committee of the Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan. The ethical approval No. is EC/PhM/AWKUM-871D.
4.8. Statistical Analysis
Data are expressed as the mean. One-way ANOVA followed by Dunnett’s test was applied. The concentration–response curve was plotted using GraphPad Prism for Windows 6.0 (GraphPad Software, San Diego, CA, USA).
4.9. List of Abbreviations
MEC: methanolic extract of Chrozophora; NBFC: n-butanol fraction of Chrozophora; KCl: potassium chloride; AchE: acetylcholine esterase; KPK: Khyber Pakhtunkhwa; DTNB: 5,5′-dithiobis-2-nitrobenzoic acid; PO: per orally; DW: distilled water; HPLC: high-performance liquid chromatography; GC-MS: gas chromatography–mass spectrometry.
5. Conclusions
Processed and refined food and low intake of fiber cause constipation and other related problems such as hemorrhoids. The utilization of herbal products with low side effects is always beneficial for the improvement of health. The different parts of herbs possess special phytochemicals that have unique biological activity. Chrozophora plants contain several important bioactive molecules which have laxative and antidepressant properties. Utilization of this plant in tea and other drinks can be useful. However, overutilization may have other side effects that should be avoided. Further work is needed to isolate the phytochemicals that act as diarrheal agents in Chrozophora tinctoria.
Acknowledgments
We appreciate our universities (Islamia College University Peshawar and King Abdullah University of Science and Technology) for their support in completion and publication of this work.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules27134321/s1, Table S1: Structures of compounds of methanolic extract of Chrozophora tinctoria (MEC); Table S2: Structures of compounds of n-Butanol extract of Chrozophora tinctoria (NBFC).
Author Contributions
Conceptualization, A.I. and A.A.S.; methodology, A.A.S.; software, N.M.; validation, A.I.; formal analysis, A.A.S.; investigation, A.A.S.; resources, N.M.; data curation, A.I., S.L.B.; writing—original draft preparation, A.I. and A.A.S.; writing—review and editing, S.L.B., A.-H.E. and M.J.; visualization, A.A.S.; supervision, A.I. and N.M.; project administration, A.I.; funding acquisition, M.J. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
The study was approved by the ethical committee of the Department of Pharma-cy, Abdul Wali Khan University, Mardan, Pakistan. The ethical approval No. is EC/PhM/AWKUM-871D.
Informed Consent Statement
Not applicable.
Data Availability Statement
Data will be provided upon request.
Conflicts of Interest
The authors declare no conflict of interest.
Sample Availability
Samples of the extracts are available from the authors.
Funding Statement
We are thankful to King Abdullah University of Science and Technology for their financial support.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Woodward S. Assessment and management of constipation in older people. Nurs. Older People. 2012;24:21–26. doi: 10.7748/nop2012.06.24.5.21.c9115. [DOI] [PubMed] [Google Scholar]
- 2.Schiller L.R. Review article: The therapy of constipation. Aliment. Pharmacol. Ther. 2001;15:749–763. doi: 10.1046/j.1365-2036.2001.00982.x. [DOI] [PubMed] [Google Scholar]
- 3.Gritsanapan W. Ethnomedicinal plants popularly used in Thailand as laxative drugs. Drugs. 2010;661:295–315. [Google Scholar]
- 4.Kim J.E., Choi Y.J., Lee S.J., Gong J.E., Lee Y.J., Sung J.E., Jung Y.S., Lee H.S., Hong J.T., Hwang D.Y. Antioxidant activity and laxative effects of tannin-enriched extract of Ecklonia cava in loperamide-induced constipation of SD rats. PLoS ONE. 2021;16:e0246363. doi: 10.1371/journal.pone.0246363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jabri M.A., Wannes D., Hajji N., Sakly M., Marzouki L., Sebai H. Role of laxative and antioxidant properties of Malva sylvestris leaves in constipation treatment. Biomed. Pharmacother. 2017;89:29–35. doi: 10.1016/j.biopha.2017.02.020. [DOI] [PubMed] [Google Scholar]
- 6.Tessema M.Y., Wubneh Z.B., Asrie A.B. Laxative Activities of 80% Methanolic Extract of the Leaves of Grewia ferruginea Hochst Ex A Rich in Mice. J. Evid. Based Integr. Med. 2020;25:2515690X20926922. doi: 10.1177/2515690X20926922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Vilanova-Sanchez A., Gasior A.C., Toocheck N., Weaver L., Wood R.J., Reck C.A., Wagner A., Hoover E., Gagnon R., Jaggers J., et al. Are Senna based laxatives safe when used as long term treatment for constipation in children? J. Pediatr. Surg. 2018;53:722–727. doi: 10.1016/j.jpedsurg.2018.01.002. [DOI] [PubMed] [Google Scholar]
- 8.Wintola O.A., Sunmonu T.O., Afolayan A.J. The effect of Aloe ferox Mill. In the treatment of loperamide-induced constipation in Wistar rats. BMC Gastroenterol. 2010;10:95. doi: 10.1186/1471-230X-10-95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Altabas K., Bilić A., Jurčić D., Dorosulić Z., Mihanović M., Šunić-Omejc M., Restek-Petrović B., Tolj N. The efficacy of cisapride vs. placebo and diet in patients with chronic constipation. Coll. Antropol. 2003;27:197–204. [PubMed] [Google Scholar]
- 10.Sher A.A., Bakht J., Khan K. Antinociceptive, antipyretic and antimicrobial activities of chrozophora tinctoria extracts. Indian J. Pharm. Sci. 2018;80:533–540. doi: 10.4172/pharmaceutical-sciences.1000388. [DOI] [Google Scholar]
- 11.Ahmed F.A. Phytochemical studies on Chrozophora tinctoria (L.) Raf. growing naturally in South Sinai. Bull. Agric. Univ. Cairo. 2003;54:93–110. doi: 10.21608/ejarc.2003.225135. [DOI] [Google Scholar]
- 12.Hawas U.W. Antioxidant activity of brocchlin carboxylic acid and its methyl ester from Chrozophora brocchiana. Nat. Prod. Res. 2007;21:632–640. doi: 10.1080/14786410701371124. [DOI] [PubMed] [Google Scholar]
- 13.Tabussum A., Riaz N., Saleem M., Ashraf M., Ahmad M., Alam U., Jabeen B., Malik A., Jabbar A. α-Glucosidase inhibitory constituents from Chrozophora plicata. Phytochem. Lett. 2013;6:614–619. doi: 10.1016/j.phytol.2013.08.005. [DOI] [Google Scholar]
- 14.Golkar P., Taghizadeh M., Jalali S.A.H. Determination of phenolic compounds, antioxidant and anticancer activity of Chrozophora tinctoria accessions collected from different regions of Iran. J. Food Biochem. 2019;43:e13036. doi: 10.1111/jfbc.13036. [DOI] [PubMed] [Google Scholar]
- 15.Delazar A., Talischi B., Nazemiyeh H., Rezazadeh H., Nahar L., Sarker S.D. Chrozophorin: A new acylated flavone glucoside from Chrozophora tinctoria (Euphorbiaceae) Rev. Bras. Farmacogn. 2006;16:286–290. doi: 10.1590/S0102-695X2006000300002. [DOI] [Google Scholar]
- 16.Badshah S.L., Faisal S., Muhammad A., Poulson B.G., Emwas A.H., Jaremko M. Antiviral activities of flavonoids. Biomed. Pharmacother. 2021;140:111596. doi: 10.1016/j.biopha.2021.111596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ullah A., Munir S., Badshah S.L., Khan N., Ghani L., Poulson B.G., Emwas A.H., Jaremko M. Important flavonoids and their role as a therapeutic agent. Molecules. 2020;25:5243. doi: 10.3390/molecules25225243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ariharan V.N., Kalirajan K., Nagendra Prasad P. Gas chromatography-mass spectrometry determination of bioactive components of three traits of Vilvam (Bael) Asian J. Pharm. Clin. Res. 2015;8:338–342. [Google Scholar]
- 19.Cruz S.L., Rivera-García M.T., Woodward J.J. Review of Toluene Actions: Clinical Evidence, Animal Studies, and Molecular Targets. J. Drug Alcohol Res. 2014;3:235840. doi: 10.4303/jdar/235840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ramirez K., Sheridan J.F. Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive-like behaviors. Brain Behav. Immun. 2016;57:293–303. doi: 10.1016/j.bbi.2016.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Krishnamoorthy K., Subramaniam P. Phytochemical Profiling of Leaf, Stem, and Tuber Parts of Solena amplexicaulis (Lam.) Gandhi Using GC-MS. Int. Sch. Res. Not. 2014;2014:567409. doi: 10.1155/2014/567409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mai C., Son M.H., Thermal I. Butylated Hydroxytoluene in Edible Vegetable Oils from Local Markets of Chiang Mai and Mae Hong Son and Its Thermal Stability in Different Cooking Conditions. Thai J. Toxicol. 2009;24:113–118. [Google Scholar]
- 23.Elaiyaraja A., Chandramohan G. Comparative Phytochemical Profile of Crinum Defixum Ker-Gawler Leaves Using GC-MS. J. Drug Deliv. Ther. 2018;8:365–380. [Google Scholar]
- 24.Sudha T., Chidambarampillai S., Mohan V.R. GC-MS analysis of bioactive components of aerial parts of Fluggea leucopyrus willd. (Euphorbiaceae) J. Appl. Pharm. Sci. 2013;3:126–130. doi: 10.7324/JAPS.2013.3524. [DOI] [Google Scholar]
- 25.Wintola O.A., Afolayan A.J. Ethnobotanical survey of plants used for the treatment of constipation within nkonkobe municipality of south africa. Afr. J. Biotechnol. 2010;9:7767–7770. doi: 10.1016/j.sajb.2010.02.056. [DOI] [Google Scholar]
- 26.Mukherjee P.K., Kumar V., Mal M., Houghton P.J. Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007;14:289–300. doi: 10.1016/j.phymed.2007.02.002. [DOI] [PubMed] [Google Scholar]
- 27.Sivaraman D., Panneerselvam P., Muralidharan P. In-vitro screening for acetylcholinesterase enzyme inhibition potential and antioxidant activity of extracts of Ipomoea aquatica Forsk: Therapeutic lead for Alzheimer’s disease. J. Appl. Pharm. Sci. 2015;5:12–16. [Google Scholar]
- 28.Maya M., Sarada S. In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of Ayurvedic medicinal plants used for cognitive disorders. PLoS ONE. 2014;9:e86804. doi: 10.1371/journal.pone.0086804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Badshah S.L., Khan A.N., Mabkhot Y.N. Molecular Dynamics Simulation of Cholera Toxin A-1 Polypeptide. Open Chem. 2016;14:188–196. doi: 10.1515/chem-2016-0021. [DOI] [Google Scholar]
- 30.Badshah S.L., Naeem A. Computational Simulation of Conjugated Cholera Toxin Protein. Mol. Genet. Microbiol. Virol. 2021;36:S13–S22. doi: 10.3103/S0891416821050049. [DOI] [Google Scholar]
- 31.Ali N., Shah I., Shah S.W.A., Ahmed G., Shoaib M., Junaid M., Ali W., Ahmed Z. Antioxidant and relaxant activity of fractions of crude methanol extract and essential oil of Artemisia macrocephala jacquem. BMC Complement. Altern. Med. 2013;13:96. doi: 10.1186/1472-6882-13-96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sher A.A., Afzal M., Bakht J. Pharmacological evaluation of different extracts of Forsskaolea tenacissima. Indian J. Pharm. Sci. 2017;79:257–266. doi: 10.4172/pharmaceutical-sciences.1000224. [DOI] [Google Scholar]
- 33.Sher A.A., Iqbal A., Adil M., Ullah S., Bawazeer S., Binmahri M.K., Zamil L.Z., Irfan M. GC-MS analysis of organic fractions of Chrozophora tinctoria (L.) A.Juss. and their prokinetic propensity in animal models. Braz. J. Biol. 2022;84 doi: 10.1590/1519-6984.260566. [DOI] [PubMed] [Google Scholar]
- 34.Shah Z., Badshah S.L., Iqbal A., Shah Z., Emwas A.H., Jaremko M. Investigation of important biochemical compounds from selected freshwater macroalgae and their role in agriculture. Chem. Biol. Technol. Agric. 2022;9:9. doi: 10.1186/s40538-021-00273-0. [DOI] [Google Scholar]
- 35.Alam M., Uddin G., Siddiqui B.S., Sadat A., Khan A.A., Rauf A. Gas chromatography-mass spectrometry (GC-MS) analysis, antimicrobial, phytotoxic, insecticidal and leishmanicidal activities of fixed oil from Viburnum grandiflorum. Afr. J. Pharm. Pharmacol. 2014;8:1173–1179. [Google Scholar]
- 36.Löfmark S., Edlund C., Nord C.E. Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections. Clin. Infect. Dis. 2010;50:S16–S23. doi: 10.1086/647939. [DOI] [PubMed] [Google Scholar]
- 37.Cudmore S.L., Delgaty K.L., Hayward-McClelland S.F., Petrin D.P., Garber G.E. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin. Microbiol. Rev. 2004;17:783–793. doi: 10.1128/CMR.17.4.783-793.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Méité S., Bahi C., Yéo D., Datté J.Y., Djaman J.A., N’guessan D.J. Laxative activities of Mareya micrantha (Benth.) Müll. Arg. (Euphorbiaceae) leaf aqueous extract in rats. BMC Complement. Altern. Med. 2010;10:7. doi: 10.1186/1472-6882-10-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sher A.A., Iqbal A., Muhammad N., Badshah S.L., Emwas A.-H., Jaremko M. Prokinetic and Laxative Effects of Chrozophora tinctoria Whole Plant Extract. Molecules. 2022;27:2143. doi: 10.3390/molecules27072143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Muhammad N., Ullah S., Abu-Izneid T., Rauf A., Shehzad O., Atif M., Khan H., Naz H., Herrera-Calderon O., Khalil A.A., et al. The pharmacological basis of Cuscuta reflexa whole plant as an antiemetic agent in pigeons. Toxicol. Rep. 2020;7:1305–1310. doi: 10.1016/j.toxrep.2020.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88–95. doi: 10.1016/0006-2952(61)90145-9. [DOI] [PubMed] [Google Scholar]
- 42.Badshah S.L., Riaz A., Muhammad A., Çayan G.T., Çayan F., Duru M.E., Ahmad N., Emwas A.H., Jaremko M. Isolation, characterization, and medicinal potential of polysaccharides of Morchella esculenta. Molecules. 2021;26:1459. doi: 10.3390/molecules26051459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Joshi C.S., Priya E.S., Venkataraman S. Acute and subacute toxicity studies on the polyherbal antidiabetic formulation Diakyur in experimental animal models. J. Health Sci. 2007;53:245–249. doi: 10.1248/jhs.53.245. [DOI] [Google Scholar]
- 44.Ullah I. Role of gastrointestinal motility/gastric emptying in cisplatin-induced vomiting in pigeon. Afr. J. Pharm. Pharmacol. 2012;6:2592–2599. doi: 10.5897/AJPP12.530. [DOI] [Google Scholar]
- 45.Ali N., Alam H., Khan A., Ahmed G., Shah W.A., Nabi M., Junaid M. Antispasmodic and antidiarreal activity of the fruit of Rosa moscha. BMC Complement. Altern. Med. 2014;14:485. doi: 10.1186/1472-6882-14-485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ali N., Ahmad B., Ali Shah S.W. Spasmogenic and spasmolytic activities of Onosma griffithii Vatke. Pak. J. Pharm. Sci. 2011;24:553–558. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data will be provided upon request.